Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT05702567
Eligibility Criteria:
Inclusion Criteria:
* Women between 20 - 75 years
* Previously diagnosed SUI through assessment and questionnaires.
* PAD Test of 1h with \> or = 1gr of urine loss.
* Urine losses in the last week.
* Nulliparous and multiparous.
Exclusion Criteria:
* Women \> 75 years.
* Another type of urinary incontinence, urge or mixed.
* Difficulty urinating
* Hematuria
* Pregnancy
* Patients with any type of cancer or with a personal history of it.
* Previous surgeries for the treatment of SUI
* Gynecological surgeries (hysterectomy, containment mesh for different prolapses).
* Neurological and cognitive problems.
* Injury to the spinal cord, lower limbs or pelvis.
* Grade II, III or IV pelvic organ prolapse.
* Vaginal or urinary infection.
* Drugs:
* Antimuscarinics (oxybutinin)
* Toterodine
* Trospium
* Solifenacin
* Darifenacin
* Fesoterodine
* Atropine
* Anticholinergics
* Antidepressants:
* Duloxetine
* Imipramine
* Estrogens
* Botulinum Toxin
* Alpha-adrenergic agonists
* Ephedrine
* Pseudoephedrine
* Antidiuretics (desmopressin)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT05702567
Study Brief:
Protocol Section:
NCT05702567